AngioDynamics posts higher revenues, loss in Q1

By staff writers

September 29, 2020 -- Signs of recovery among its customers from the COVID-19 pandemic helped interventional technology developer AngioDynamics to produce a 6.3% increase in revenue in its 2021 fiscal first quarter.

For the period (end-August 31), the company had sales of $70.2 million, up from $66 million in the fiscal first quarter of 2020. However, AngioDynamics reported a net loss of $4.3 million, compared with a net loss of approximately $1.3 million in the same period a year ago.

Looking ahead, AngioDynamics said it expects sales in fiscal 2021 will range between $278 and $284 million, with adjusted earnings per share of $0.00 to $0.05.

Copyright © 2020

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking